← Back to Search

Behavioral Intervention

Nutrition Coaching for Pancreatic Cancer

N/A
Recruiting
Led By Sylvia Crowder, PhD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 months
Awards & highlights

Study Summary

This trial will test a food/nutrition coaching program to help cancer patients during chemotherapy.

Who is the study for?
This trial is for adults over 18 with newly diagnosed, non-metastatic pancreatic cancer who are about to start chemotherapy and can eat by mouth. They must be able to understand English and give verbal consent. People with serious mental disorders or those on tube feeding, pregnant women, or patients with bowel obstruction risks cannot join.Check my eligibility
What is being tested?
The study tests a remote nutrition coaching program during the first 12 weeks of chemotherapy for pancreatic cancer. It includes dietary assessments using questionnaires, educational materials on nutrition, personalized coaching sessions, and follow-up surveys to measure cognitive function and quality of life.See study design
What are the potential side effects?
Since this trial focuses on nutritional support rather than medication, there may not be direct side effects like those seen in drug trials. However, participants might experience discomfort from frequent monitoring or stress from adherence to the intervention's requirements.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence - Feasibility
Recruitment Rate -Feasibility
Retention Rate - Feasibility
Secondary outcome measures
Participant Satisfaction with Overall Program- Acceptability
Participant intent to continue using skills- Acceptability
Participant perception of utility of knowledge gained - Acceptability
Other outcome measures
Treatment Effect - Quality of Life

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MONITOR group: Monitoring of a Nutrition Intervention to Optimize treatment ResponseExperimental Treatment6 Interventions
Participants randomized to the MONITOR arm will be provided dietary coaching biweekly to discuss nutrition concerns, anti-inflammatory diet compliance, and set SMART goals based on their most recent Vioscreen food frequency questionnaires.
Group II: Standard Usual CareActive Control5 Interventions
Standard Usual Care participants will receive usual nutrition care received in the Moffitt Cancer Center pancreatic clinic, in addition to handouts on diet.

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
543 Previous Clinical Trials
135,442 Total Patients Enrolled
Sylvia Crowder, PhDPrincipal InvestigatorMoffitt Cancer Center
1 Previous Clinical Trials
40 Total Patients Enrolled
Pamela Hodul, MDPrincipal InvestigatorMoffitt Cancer Center
4 Previous Clinical Trials
173 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots to join this experiment?

"As indicated on clinicaltrials.gov, this experiment is welcoming new participants. It was introduced to the public on September 8th 2023 and revised most recently on September 15th of the same year."

Answered by AI

What is the current capacity for enrolment in this clinical experiment?

"Yes, the evidence on clinicaltrials.gov confirms that as of 9/15/2023, this medical research is still looking for volunteers. The study was first advertised on September 8th and requires 40 participants from a single site."

Answered by AI
~20 spots leftby Dec 2024